LRRK2 and Parkinson disease: Of interest, clinical phenotypes of PD patients carrying mutated forms of LRRK2 are very similar to the clinical manifestation in idiopathic PD, suggesting that LRRK2 may mediate pathogenic mechanisms relevant to all forms of PD (Marras et al., 2011; Langston et al., 2015).